Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitor implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.
2025 · 3rd Quarter (July 1 - Sep 30)
IPSEN BIOPHARMACEUTICALS, INC.
Filed by CAPITOL COUNSEL LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 17, 2025
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- CAPITOL COUNSEL LLC
- Filing UUID
- 06b73eca-2754-4ab1-913d-28efe4dc1a6d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to international tax.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.